The unit of analysis error in studies about physicians' patient care behavior
The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
Objective To estimate the frequency with which patients are incorrectly used as the unit of analysis among statistical calculations in published studies of physicians' patient care behavior. Design Retrospective review of studies published during 1980-1990. ARTICLES: 54 articles retrieved by a computerized search using medical subject headings for physicians and study characteristics. Article selection criteria included the requirement that the physician should have been the correct unit of analysis. Intervention Presence of the error was determined by consensus using published criteria. Main results The error was present in 38 articles (70%). The number of study physicians was reported in 35 articles (65%). The error was found in 57% of articles that reported the number of study physicians and in 95% of those that did not. The error rate was not lower among articles published more recently nor among those published in journals with higher rates of article citations in the medical literature. Conclusion The unit of analysis error occurs frequently and can generate artificially low p values. Failure to report the number of study physicians can be a clue that this type of error has been made.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Authors often fail to account for intraclass correlation in clustered studies, leading to a 'unit of analysis' error (Divine 1992), whereby P values are spuriously low, CIs unduly narrow and statistical significance overestimated.”
From Compulsory community and involuntary outpatient treatment for people with severe mental disorders. (2017) · cites this paper as Divine 1992
Citations
Cites
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
SCHEFFE, H. (1960) · Soil Science · doi:10.1097/00010694-196006000-00016 · Cited by 5,516
Some statistical methods useful in circulation research.
Wallenstein, S., Zucker, C. L., & Fleiss, J. L. (1980) · Circulation Research · doi:10.1161/01.res.47.1.1 · Cited by 3,886
Freiman, J. A., Chalmers, T. C., Smith, H., & Kuebler, R. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197809282991304 · Cited by 1,628 · cited 3×
“1980 2 (4) 2 (100) 2 (100) 2 ( 1 O0 1981 0 - - - 1982 6 ( 11 ) 5 (83) 2 (33) 4 (67) 1983 5 (9) 4 (80) 3 (60) 3 (60) 1984 6 (11) 5 (83) 5 (83) 3 (50) 1985 5 (9) 4 (80) 4 (80) 3 (60) 1986 4 (7) 4 (100) 2 (50) 3 (75) 1987 9 (17) 7 (78) 5 (56) 7 (78) 1988 4 (7) 3 (75) 3 (75) 3 (75) 1989 11 (20) 11 (100) 7 (64) 8 (73) 1990…”
Comparing the Means of Several Groups
Godfrey, K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132305 · Cited by 737
Statistical Problems in the Reporting of Clinical Trials
Pocock, S. J., Hughes, M. D., & Lee, R. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170706 · Cited by 662 · cited 1×
“1980 2 (4) 2 (100) 2 (100) 2 ( 1 O0 1981 0 - - - 1982 6 ( 11 ) 5 (83) 2 (33) 4 (67) 1983 5 (9) 4 (80) 3 (60) 3 (60) 1984 6 (11) 5 (83) 5 (83) 3 (50) 1985 5 (9) 4 (80) 4 (80) 3 (60) 1986 4 (7) 4 (100) 2 (50) 3 (75) 1987 9 (17) 7 (78) 5 (56) 7 (78) 1988 4 (7) 3 (75) 3 (75) 3 (75) 1989 11 (20) 11 (100) 7 (64) 8 (73) 1990…”
Statistics with applications to the biological and health sciences
Remington, R. D., & Schork, M. A. (1970) · Medical Entomology and Zoology · Cited by 521
Central Vein Catheterization: Failure and Complication Rates by Three Percutaneous Approaches
Sznajder, J. I. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360140065007 · Cited by 496
A Randomized Trial of Continuing Medical Education
Sibley, J. C., Sackett, D. L., Neufeld, V., Gerrard, B., Rudnick, K. V., & Fraser, W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203043060904 · Cited by 342
A Randomized Trial of a Family Physician Intervention for Smoking Cessation
Wilson, D. M. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410110078031 · Cited by 239
Research works printed but not linked: 1
- Snedecor GW, Cochran WG. Statistical methods, 7th ed. Ames, IA: Iowa State University Press, 1980.
Cited by
Items 501–600 of 750
Pharmacological interventions for reducing weight gain in schizophrenia
Hahn, M., Remington, G. J., Duncan, M. J., Cohn, T. A., & Faulkner, G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011127 · Cited by 6
Self management programme for ankylosing spondylitis
Spencer, S., Martindale, J. H., MacPhie, E. M., & Montgomery, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006977.pub2 · Cited by 6
Brief Family Intervention for Schizophrenia
Okpokoro, U., & Sampson, S. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu039 · Cited by 7
Magnetic seizure therapy for people with schizophrenia
Wu, H., Jiang, J., Cao, X., Wang, J., & Li, C. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012697.pub2 · Cited by 10
Bifeprunox versus placebo for schizophrenia
Chattopadhyay, A., Frey, S., & Green, G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012029.pub2 · Cited by 6
Quetiapine dose for people with schizophrenia
Iqbal, Y., Connell, C., Worthington, M., Elrafei, H., Mulvaney, C. A., & Kaewchaluay, C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013372 · Cited by 6
Paliperidone for schizophrenia
Nussbaum, A. M., & Stroup, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006369 · Cited by 6
Supportive therapy for schizophrenia
Buckley, L., & Pettit, T. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004716.pub2 · Cited by 8
De-escalation techniques for psychosis-induced aggression or agitation
Rao, H., Yeung, W.-L., & Jayaram, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009922 · Cited by 6
Fluphenazine versus low-potency first generation antipsychotic drugs for schizophrenia
Tardy, M., Leucht, S., Potapov, A., Engel, R. R., Huhn, M., & Kissling, W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009230 · Cited by 6
Risperidone dose for schizophrenia
Li, C., Xia, J., & Wang, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007474 · Cited by 6
Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia
Tardy, M., Leucht, S., Potapov, A., Engel, R. R., Dold, M., & Kissling, W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009396 · Cited by 6
Social skills programmes for schizophrenia
Almerie, M. Q., Marhi, M. O. A., Alsabbagh, M., Jawoosh, M., Matar, H. E., & Maayan, N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009006 · Cited by 7
Yoga versus non-standard care for schizophrenia
Broderick, J. M., Crumlish, N., Waugh, A., & Vancampfort, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012052 · Cited by 7
Advance treatment directives for people with severe mental illness
Campbell, L. A., & Kisely, S. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005963 · Cited by 6
Wendan decoction (Traditional Chinese medicine) for schizophrenia
Deng, H., & Xu, J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012217 · Cited by 6
Ballesteros, J., Moreno-Calvete, M. C., Santos‐Zorrozúa, B., & González–Fraile, E. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013511.pub2 · Cited by 8
Quetiapine versus placebo for schizophrenia
Lankappa, S. T., & Gandhi, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009935 · Cited by 5
Illness management and recovery programme for people with severe mental illness
Korsbek, L., Dalum, H. S., Lindschou, J., & Eplov, L. F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011071 · Cited by 5
Peer support for schizophrenia
Chien, W. T., Lui, S., & Clifton, A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010880 · Cited by 7
Animal-assisted therapy for people with serious mental illness
Downes, M., Dean, R. S., & Bath-Hextall, F. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010818 · Cited by 12
Liu, Y., Li, B., Furness, T., Xia, J., Joseph, C. W., Tang, X., Zheng, J., & Wang, Z. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011473 · Cited by 5
Olanzapine dose for people with schizophrenia
Latifeh, Y., Mohsen, M., Mohamad, S., & Nassif, T. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013266 · Cited by 7
Specialised early intervention teams (extended time) for first episode psychosis
Puntis, S., Minichino, A., Crescenzo, F. D., Cipriani, A., & Lennox, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013287 · Cited by 5
Crespi, C. M., & Ziehl, K. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106974 · Cited by 5
Saffron (adjunct) for people with schizophrenia who have antipsychotic-induced metabolic syndrome
Zare, M., Bazrafshan, A., Afshar, R. M., & Mazloomi, S. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012950 · Cited by 5
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms
Huang, M. W., Gibson, R. C., Moberg, P. J., & Caroff, S. N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013100 · Cited by 5
de Santiago, A. I., & Khan, M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004160.pub2 · Cited by 5
Management of sexual dysfunction due to antipsychotic drug therapy
Berner, M., & Hagen, M. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003546 · Cited by 5
Asenapine versus placebo for schizophrenia
Hay, A., Byers, A., Sereno, M., Basra, M. K., Dutta, S., & Jalil, I. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011458 · Cited by 7
General physical health advice for people with serious mental illness
Tosh, G. E., Clifton, A., Mala, S., & Bachner, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008567 · Cited by 6
Chlorpromazine versus penfluridol for schizophrenia
Khalili, N., Vahedian, M., Nikvarz, N., & Piri, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011831 · Cited by 5
Horticultural therapy for schizophrenia
Roberts, S., & Bradley, A. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009413 · Cited by 4
Ibragimov, K., Keane, G., Glaría, C. C., Cheng, J. J., & Llosa, A. E. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013425.pub2 · Cited by 7
Transitional discharge interventions for people with schizophrenia
Rodríguez, P. R., Chen, X., Arancibia, M., Garegnani, L., Liquitay, C. M. E., Mohammad, H. A., & Franco, J. V. A. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009788.pub3 · Cited by 6
Haloperidol versus risperidone for schizophrenia
Ray, S., Ray, A., Gopi, A., & Hunter, R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012728 · Cited by 4
Clozapine (generic versus branded) for people with schizophrenia
Turkmani, K., Marwa, M. E., Ahmad, B., Ahmad, T., Alrstom, A., & Essali, A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013248 · Cited by 4
Aripiprazole versus haloperidol for people with schizophrenia and schizophrenia-like psychoses
Bhattacharjee, J., & El-Sayeh, H. G. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012073 · Cited by 4
Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia
Samara, M. T., Helfer, B., Rothe, P., & Leucht, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011884 · Cited by 4
Meta-cognitive training for schizophrenia
Guaiana, G., Lucarini, V., Ebuenyi, I. D., Abbatecola, M., Tarantino, F., Santoro, A., Ghiandi, G., Cappiello, A., & Pinto, A. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015490 · Cited by 5
Risperidone (oral forms) for people with schizophrenia
Turk, T., Alkhatib, M., Abbas, G., Jawish, M. K., Alshar, O. M. H., Alchamat, H. A., & Essali, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012822 · Cited by 4
Clozapine versus risperidone for people with schizophrenia
Lobos, C. A., Cortés-Jofré, M., Fonseca, C., Leucht, S., Madrid, E., & Bonfill, X. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013221 · Cited by 5
Haloperidol versus olanzapine for people with schizophrenia
Ibragimov, K., Keane, G., Glaría, C. C., Cheng, J., & Llosa, A. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013425 · Cited by 6
Chalu, H. Z. (2019) · Tanzanian Economic Review · doi:10.56279/ter.v9i2.46 · Cited by 6
“Similarly, Divine et al. (1992) considered that some studies fall in between the spectrum of the two operations, whereby at one end of the spectrum there are standardized protocols to be followed, while at the other there are considerable variations due to differences in attitudes and knowledge.”
BackgroundAntipsychotic dose reduction compared to dose continuation for people with schizophrenia
Bighelli, I., Samara, M. T., Rodolico, A., Hansen, W., & Leucht, S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014384 · Cited by 4
Interventions for ulceration and other skin changes caused by nerve damage in leprosy
Reinar, L. M., Forsetlund, L., Brurberg, K. G., & Lehman, L. F. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012235 · Cited by 4
Benzodiazepines for generalised anxiety disorder (GAD)
Gale, C. K., Herbison, P., Glue, P., Coverdale, J., & Guaiana, G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001846.pub3 · Cited by 6
RetractedAnticholinergics versus placebo for neuroleptic-induced parkinsonism
Dickenson, R., Momčilović, S., & Donnelly, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011164 · Cited by 4
Risk assessment for aggressive behaviour in schizophrenia
Valimaki, M. A., Lantta, T., Hätönen, H. M., Kontio, R., & Zhang, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012397 · Cited by 6
Antidepressants versus placebo for generalised anxiety disorder (GAD)
Guaiana, G., Barbui, C., & Abouhassan, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012942 · Cited by 4
Selective noradrenaline reuptake inhibitors for schizophrenia
Matthews, P., & Horder, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010219 · Cited by 4
Acetylsalicylic acid (aspirin) for schizophrenia
Roberts, T., Shokraneh, F., & Nur, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012116 · Cited by 4
Olanzapine versus placebo for people with schizophrenia
Li, Y., Du, C., Jiaxiang, N., Liqiang, Y., & Qi, F. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013310 · Cited by 4
Second-generation antipsychotic drugs for obsessive compulsive disorder
Komossa, K., Depping, A. M., Kissling, W., & Leucht, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008141 · Cited by 4
Repetitive transcranial magnetic stimulation (rTMS) for panic disorder
Xiao, Z., Li, C., & Wang, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009083 · Cited by 4
Sertindole versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel‐Kluge, C., Hunger, H., Schwarz, S., Schmidt, F., Lewis, R. A., Kissling, W., & Leucht, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006752 · Cited by 4
Ziprasidone versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel‐Kluge, C., Hunger, H., Schmidt, F., Schwarz, S., Bhoopathi, P. S., & Leucht, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006627 · Cited by 4
Chlorpromazine versus metiapine for schizophrenia
Zare, M., Bazrafshan, A., Okhovati, M., Mazhari, S., & Mousavi, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011655 · Cited by 4
Cognitive behaviour therapy versus psychosocial treatments for schizophrenia
Jones, C., Hacker, D., Cormac, I., Meaden, A., & Irving, C. B. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008712 · Cited by 5
Transcranial magnetic stimulation for schizophrenia
Dougall, N. J., McIntosh, A. M., & Ebmeier, K. P. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006081 · Cited by 4
Perphenazine for schizophrenia
Leucht, S., & Hartung, B. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003443 · Cited by 4
Interventions to encourage uptake of cancer screening for people with severe mental illness
Barley, E. A., Borschmann, R., Walters, P., & Tylee, A. T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009641 · Cited by 4
Virtual reality for treatment compliance for people with serious mental illness
Valimaki, M. A., Hätönen, H. M., Lahti, M., Kurki, M., Hottinen, A., Metsäranta, K., Riihimäki, T., & Adams, C. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009928 · Cited by 4
Amisulpride versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel‐Kluge, C., Hunger, H., Schmidt, F., Schwarz, S., Neto, J. I. S. D. M., Kissling, W., & Leucht, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006624 · Cited by 4
Akhondzadeh, S., Modabbernia, A., Taslimi, S., Daneshmand, A., & Ostovaneh, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009205 · Cited by 3
Asenapine versus typical antipsychotics for schizophrenia
Kumar, A., Narayan, M., Raja, H., & Mathen, M. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010230 · Cited by 3
Asenapine versus other atypical antipsychotics for schizophrenia
Preda, A., & Faziola, L. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008902 · Cited by 3
Aripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychoses
Bhattacharjee, J., & El-Sayeh, H. G. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012072 · Cited by 3
Humour-based interventions for people with schizophrenia
Tsujimoto, Y., Nakamura, Y., Banno, M., Kohmura, K., Tsujimoto, H., & Kataoka, Y. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013367.pub2 · Cited by 4
Clonazepam add-on therapy for refractory epilepsy in adults and children
Song, L., Liu, F., Zhang, R., Ji, H., & Jia, Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012253 · Cited by 3
Increasing antipsychotic dose for non response in schizophrenia
Helfer, B., Leucht, S., Rothe, P., & Samara, M. T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011883 · Cited by 3
Risk assessment for aggressive behaviour in schizophrenia
Valimaki, M. A., Lantta, T., & Kontio, R. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012397.pub2 · Cited by 10
Transitional discharge techniques for people with serious mental illness
Rezk, E., Mohammad, H. A., Haikal, A., & Albakour, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009788 · Cited by 3
Olanzapine depot for schizophrenia
Mudiyanselage, I. H., Alagarsamy, J., Kachhap, S., & Jayaram, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007947 · Cited by 3
Cariprazine versus placebo for schizophrenia
Essali, N., Hanafi, I., & Essali, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012207 · Cited by 3
Cognitive remediation therapy plus standard care versus standard care for people with schizophrenia
Pentaraki, A., Utoblo, B., & Kokkoli, E. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012865 · Cited by 3
RetractedZuclopenthixol versus placebo for schizophrenia
Lacey, M., & Jayaram, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010598.pub2 · Cited by 5
Behavioural interventions for reducing weight gain in schizophrenia
Faulkner, G., Duncan, M. J., Hahn, M., Remington, G. J., & Cohn, T. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010781 · Cited by 5
From Trees to Wood and Back: Perspective on Clinical Data Analysis in Thoracic Surgery
Blackstone, E. H., & Rice, T. W. (2007) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2007.07.005 · Cited by 3
Omega-3 fatty acids for bipolar disorder (Review)
Montgomery, P., & Aj, R. (2009) · Cited by 3
Pharmacological interventions for acute and transient psychotic disorder (ATPD)
Farooq, S., Rehman, M., & Naeem, F. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011974 · Cited by 4
Brexpiprazole versus placebo for people with schizophrenia
Bazrafshan, A., Zare, M., Bazrafshani, M. S., Zare, F., & Mazhari, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012580 · Cited by 3
Parenting interventions for people with schizophrenia or related serious mental illness
Radley, J., Grant, C., Barlow, J., & Johns, L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013536 · Cited by 4
“Divine 1992 Divine GW, Brown JT, Frazier LM.”
BackgroundFattahi, M. R., Fattahi, M. R., Azimi, A. R., Sadeghi, M., Torbati, M. S., & Azimi, A. R. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13815 · Cited by 4
Generating New Knowledge in Cardiac Interventions
Blackstone, E. H. (2013) · Anesthesiology Clinics · doi:10.1016/j.anclin.2012.12.006 · Cited by 3
“It is a study design in which the unit of randomization (physician) is not the unit of analysis (individual patient outcome).(9)”
BackgroundThe Structure of Intensive Care
Rubenfeld, G. D. (2002) · Springer eBooks · doi:10.1007/978-1-4615-6939-8_3 · Cited by 3
Fluphenazine decanoate (timing of administration) for people with schizophrenia
Abbas, F., Rajab, T. M., Alsamarrai, O., Alhalabi, N., Addeen, S. Z., Mheish, O., Aljojo, A., & Essali, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012810 · Cited by 3
Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms
Pereira, S. R., & Michael, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012525 · Cited by 4
Temmingh, H. S., Amos, T., Siegfried, N., & Stein, D. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011057 · Cited by 5
Knowles, A., Chadwick, J., & Vancampfort, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010554 · Cited by 5
Morita therapy for anxiety disorders
Li, C., He, Y., Yu, D., Wang, J., Omori, I. M., & Xiao, Z. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008619 · Cited by 3
Evaluating and Improving Physician Prescribing
Majumdar, S. R., Lipton, H. L., & Soumerai, S. B. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch25 · Cited by 3
Chlorpromazine versus clotiapine for schizophrenia
Mazhari, S., Goughari, A. S., Esmailian, S., & Shahesmaeili, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011810 · Cited by 3
Open general medical wards versus specialist psychiatric units for acute psychoses
Hickling, F., Abel, W., & Garner, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003290 · Cited by 3
Levomepromazine for schizophrenia
Sivaraman, P., Mitra, A., & Jayaram, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007779 · Cited by 3
HIV prevention advice for people with serious mental illness
Wright, N., Akhtar, A., Tosh, G. E., & Clifton, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009639 · Cited by 3
HIV prevention advice for people with serious mental illness
Wright, N., Akhtar, A., Tosh, G. E., & Clifton, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009639.pub2 · Cited by 4
Aripiprazole versus placebo for schizophrenia
Belgamwar, R. B., & El-Sayeh, H. G. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006622 · Cited by 3
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
Sampford, J., & Sampson, S. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010832 · Cited by 3
Bromperidol decanoate (depot) for schizophrenia
Purgato, M., & Adams, C. E. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001719.pub3 · Cited by 3
Metadata
- Authors
- Divine, G. W., Brown, J. T., & Frazier, L. M.
- Affiliations
- Duke University (US)
- Venue
- Journal of General Internal Medicine
- Published
- 1992-11
- Volume
- 7
- Issue
- 6
- Pages
- 623-629
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- OpenAlex
- W2058874144
- Cited by
- 749
- References
- 67
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 12 · 2023: 9 · 2022: 16 · 2021: 6 · 2020: 12 · 2019: 27 · 2018: 36 · 2017: 37 · 2016: 47 · 2015: 47 · 2014: 46 · 2013: 50 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of General Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Health Sciences › Nursing › Research and Theory › Methodologies in Health Research and Practice
- Keywords
- statistical reporting errors, methodological quality
- MeSH terms
- Data Interpretation, Statistical, Health Services Research, Humans, Medical Audit, Physicians, Retrospective Studies, Subject Headings, MEDLINE, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.